# Korean Real-world Study on MASLD/MASH Outcomes.

> **NCT07739901** · — · ACTIVE_NOT_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 10000 (estimated)

## Conditions studied

- MASLD/MASH

## Interventions

- **OTHER:** No treatment is given

## Key facts

- **NCT ID:** NCT07739901
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-07-13
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07739901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07739901, "Korean Real-world Study on MASLD/MASH Outcomes.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07739901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*